vimarsana.com

Page 19 - நிறுவனம் ஆஃப் புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vortex Biosciences, liquid biopsy for cancer diagnosis, announces experienced start-up leader Dr Adrian Kinkaid as new CEO

BioMark Diagnostics, Inc : BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening

Lucida Medical receives CE marking for Pi, its AI-machine learning software for detecting prostate cancer from MRI, enabling faster and more accurate

Lucida Medical receives CE marking for Pi, its AI-machine learning software for detecting prostate cancer from MRI, enabling faster and more accurate prostate cancer detectionCambridge, UK – 1st June 2021: Lucida Medical Ltd, the Cambridge, UK based start-up, has completed CE marking for its new machine learni.

Overwatch Research To Develop Software Platform | Northern Ireland News, 24/05/2021

Overwatch Research To Develop Software Platform Belfast based Overwatch Research has invested almost £500,000 in Research & Development (R&D) to develop a software platform, which tackles the global issue of experimental errors in preclinical research. The new software is generating export growth in the US market, with deals secured in the last year worth millions of pounds. The company s software works by reducing errors in the logging of important data in preclinical research, improving the drug development process for global pharmaceutical companies. Overwatch s customers include Boston-based Blueprint Medicines, The Institute of Cancer Research in London and a global pharmaceutical company who recently agreed a multi-year seven-figure licence deal.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.